Incorporating Risk Factors to Identify the Indication of Post-mastectomy Radiotherapy in N1 Breast Cancer Treated with Optimal Systemic Therapy: A Multicenter Analysis in Korea (KROG 14-23)
Cancer Research and Treatment. 2017;49(3):739-747 
Risk Factors for Any First Recurrence in N1 Breast Cancer Patients After Optimal Systemic Therapy and Without Postmastectomy Radiation Therapy: A Retrospective Multicenter Analysis in Korea (KROG 14-23)
International Journal of Radiation Oncology*Biology*Physics. 2016;96(2):E33
276 poster Role of internal mammary nodal irradiation in post-mastectomy-treated breast cancer patients
Radiotherapy and Oncology. 2001;58:S77
277 poster c-erbB-2 and p53 can potentially predict clinical outcome of breast cancer treated with post-mastectomy adjuvant radiation therapy
Radiotherapy and Oncology. 2001;58:S77
Post-mastectomy radiation therapy after breast reconstruction: indication, timing and results
The Breast. 2017;32:S16-S17
661The role of adjuvant post mastectomy radiotherapy in breast cancer patients receiving or not adjuvant systemic chemotherapy
Radiotherapy and Oncology. 1996;40:S168
Identification of Risk Factors for Locoregional Recurrence in Breast Cancer Patients with Nodal Stage N0 and N1: Who Could Benefit from Post-Mastectomy Radiotherapy?
PLOS ONE. 2015;10(12):e0145463
Loco-regional recurrence risk and post-mastectomy radiotherapy in breast cancer
Radiotherapy and Oncology. 2010;97(2):360
371 POSTER Results and prognostics factors in patients with breast cancer treated with adjuvant radiotherapy after mastectomy
European Journal of Cancer Supplements. 2005;3(2):104
Post-mastectomy radiation in male breast cancer
Radiotherapy and Oncology. 2002;65(2):99-103